🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

REDUCE-AMI - First landmark trial addition to the Cardiac Trials app 📱 of 2024 ♥️ Organized under ACS —> beta blocker apps.apple.com/us/app/cardiac…

~~ Cardiac Masses ~~ Benign vs malignant on multimodality imaging #EchoFirst #yesCCTA #whycmr

Colchicine for pericarditis? 3 months of colchicine with 1-2 weeks of high dose NSAID is now standard of care for acute pericarditis, established by this landmark trial. ICAP Trial, NEJM 2013 ♥️

Impella for STEMI related cardiogenic shock? Standing as the first positive AMI-cardiogenic shock trial since the 90s, this trial showed decreased six-month mortality at the expense of bleeding/limb ischemia. DanGer Shock Trial, NEJM 2024 ♥️

Just 1 month of DAPT after ACS? This trial showed ticagrelor monotherapy after only 1 month of DAPT to decrease bleeding WITHOUT change in ischemic events. A step in the right direction to decrease risk and pill burden in our patients. ULTIMATE-DAPT Trial, Lancet 2024 ♥️

~~ Cardiac Masses ~~ Benign vs malignant on multimodality imaging #EchoFirst #yesCCTA #whycmr

Very proud of Justin Sharim MD for our new book on learning cardiac CT link.springer.com/book/10.1007/9…

This book serves as the first didactic board review book for the Cardiac CT Boards. Dedicated to both board review and a practical approach to cardiac CT interpretation. Cardiac CT — a rapidly growing imaging modality in managing cardiac disease. 📚 a.co/d/8tXH0CQ

Many thanks to Dr. Matthew Budoff Matthew Budoff MD for his mentorship on this years long project. Our new book is dedicated to being the first didactic board review book for the Cardiac CT Boards. a.co/d/4VOGGMl

Pretreating ACS with prasugrel before delineating coronary anatomy in the cath lab? Increases bleeding WITHOUT a difference in ischemic events. Waiting for anatomy via cath is a standard specific to prasugrel (unlike other P2Y12i) following this trial. ACCOAST Trial, NEJM 2013 ♥️

Beta blockers for obstructive HCM? Negative inotropes (beta blockers, calcium channel blockers, and disopyramide) have been used for obstructive HCM for decades. This small trial however is the first randomized clinical trial to demonstrate its effect. TEMPO Trial, JACC 2021 ♥️

Guideline correlation: 📚 The AFIRE Trial was in large part responsible for class I rec of DOAC monotherapy in comorbid afib + chronic CAD in the latest 2023 ACC/AHA afib guidelines 👇

TAVR in asymptomatic patients? This trial showed TAVR to improve outcomes (driven mainly by ⬇️ hospitalizations) in severe aortic stenosis but ABSENCE of symptoms — echoing the smaller RECOVERY trial in “very severe” aortic stenosis in 2020. EARLY TAVR Trial, NEJM 2024 ♥️